Lexicon Pharmaceuticalsincis A Biopharmaceutical Company Based In The Woodlandstexasfounded In 1995The Company Is Dedicated To Discoveringdevelopingand Commercializing Innovative Treatments For Human Diseasesfocusing On Precision Science And Gene Based Approacheslexicon Operates In Five Therapeutic Areasoncologygastroenterologyimmunologymetabolismand Ophthalmology The Company Has A Diverse Product Pipelineincluding Inpefasotagliflozin Which Is Approved For Heart Failure And Under Development For Type 1 Diabetes And Chronic Kidney Diseaseother Notable Candidates Include Lx9211Currently In Phase Ii Trials For Neuropathic Painand Lx9851A Preclinical Stage Drug Targeting Obesitylexicon Employs Advanced Gene Science Driven Drug Discovery Methodsutilizing Gene Knockout Technology To Validate Drug Targets And Address Unmet Patient Needswith A Commitment To Patient Centric Innovationlexicon Aims To Improve The Lives Of Those With Chronic Conditions
No conferences found for this company.
| Company Name | Lexicon Pharmaceuticals Inc |
| Country |
United States
|
| Address | 8800 Technology Forest Placethe Woodlands Texas |
| Telephone | Login to View |
| Login to View |
